Using RNAi knockdown and the dominant negative CREB1 inhibitor A‐CREB, we demonstrated that CREB1 functions as a proto‐oncogene by promoting proliferation, migration and EMT in HPV+ cervical cancer cells. Here, CREB1 is linked to cervical cancer.